Literature DB >> 25265927

Aortic dual-energy CT angiography with low contrast medium injection rate.

Jie Liu1, Pei-Jie Lv1, Runze Wu1, Yong-Gao Zhang1, Li-Li Hu1, Ping Hou1, Jian-Bo Gao1.   

Abstract

The contrast medium (CM) induced nephropathy required new CT imaging protocol. This study evaluated the feasibility of low contrast medium (CM) volume and injection flow using aortic dual-energy CT (DECT) angiography with non-linear blending technique. Sixty patients were randomly assigned to two groups: control group (n=30), single-energy CT 70 ml CM at injection rate of 5 ml/s; study group (n=30), DECT mode, 0.5 ml per kg of patient weight CM at injection rate=(weight × 0.5 ml/kg)/(4+scan time). Non-linear blending technique was used for dual-energy images. Mean attention, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of aorta were compared. The level of visible renal artery branches was scored. There was no significant difference between the two groups in the mean aortic attention, SNR and CNR (all P > 0.05). Significant difference was showed in CM injection rate (p < 0.001) and volume (P < 0.001). The renal artery score had no statistically significant difference (P=0.771). Compared conventional scan and CM injection protocol, DECT with non-linear blending technique maintained the image quality of aortic CT angiography with reduced CM volume and flow rate, which could reduce the risks associated with CM injection.

Entities:  

Keywords:  Dual-energy CT; aortic angiography; contrast medium

Mesh:

Substances:

Year:  2014        PMID: 25265927     DOI: 10.3233/XST-140454

Source DB:  PubMed          Journal:  J Xray Sci Technol        ISSN: 0895-3996            Impact factor:   1.535


  1 in total

1.  Iterative reconstruction in single-source dual-energy CT angiography: feasibility of low and ultra-low volume contrast medium protocols.

Authors:  Ping Hou; Xiangnan Feng; Jie Liu; Yue Zhou; Yaojun Jiang; Xiaochen Jiang; Jianbo Gao
Journal:  Br J Radiol       Date:  2017-06-23       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.